1. Home
  2. AZTR vs GITS Comparison

AZTR vs GITS Comparison

Compare AZTR & GITS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AZTR
  • GITS
  • Stock Information
  • Founded
  • AZTR 2014
  • GITS 2018
  • Country
  • AZTR United States
  • GITS South Korea
  • Employees
  • AZTR N/A
  • GITS N/A
  • Industry
  • AZTR Biotechnology: Pharmaceutical Preparations
  • GITS
  • Sector
  • AZTR Health Care
  • GITS
  • Exchange
  • AZTR Nasdaq
  • GITS Nasdaq
  • Market Cap
  • AZTR 5.2M
  • GITS 4.8M
  • IPO Year
  • AZTR 2023
  • GITS N/A
  • Fundamental
  • Price
  • AZTR $0.30
  • GITS $1.17
  • Analyst Decision
  • AZTR
  • GITS
  • Analyst Count
  • AZTR 0
  • GITS 0
  • Target Price
  • AZTR N/A
  • GITS N/A
  • AVG Volume (30 Days)
  • AZTR 280.4K
  • GITS 76.9K
  • Earning Date
  • AZTR 05-08-2025
  • GITS 11-20-2024
  • Dividend Yield
  • AZTR N/A
  • GITS N/A
  • EPS Growth
  • AZTR N/A
  • GITS N/A
  • EPS
  • AZTR N/A
  • GITS N/A
  • Revenue
  • AZTR $7,500.00
  • GITS N/A
  • Revenue This Year
  • AZTR N/A
  • GITS N/A
  • Revenue Next Year
  • AZTR N/A
  • GITS N/A
  • P/E Ratio
  • AZTR N/A
  • GITS N/A
  • Revenue Growth
  • AZTR N/A
  • GITS 85.47
  • 52 Week Low
  • AZTR $0.23
  • GITS $0.10
  • 52 Week High
  • AZTR $12.00
  • GITS $5.06
  • Technical
  • Relative Strength Index (RSI)
  • AZTR 39.89
  • GITS N/A
  • Support Level
  • AZTR $0.28
  • GITS N/A
  • Resistance Level
  • AZTR $0.35
  • GITS N/A
  • Average True Range (ATR)
  • AZTR 0.03
  • GITS 0.00
  • MACD
  • AZTR -0.00
  • GITS 0.00
  • Stochastic Oscillator
  • AZTR 34.45
  • GITS 0.00

About AZTR Azitra Inc

Azitra Inc is an early-stage clinical biopharmaceutical company focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products that can be applied topically to treat diseases of the skin. The company has built a proprietary platform that includes a microbial library comprised of bacterial strains that can be screened for therapeutic characteristics. The platform is augmented by artificial intelligence and machine learning technology that analyzes, predicts and helps screen the library of strains for drug-like molecules. The platform also utilizes a licensed genetic engineering technology, which can enable the transformation of previously genetically intractable strains.

About GITS Global Interactive Technologies Inc. Common Stock

Global Interactive Technologies Inc, formerly Hanryu Holdings Inc is the creator of the engaging social media platform, FANTOO. Through FANTOO, it provides a multi-media platform for its users to interact with other like-minded users, share their appreciation of various types of entertainment and cultures, create their content, enjoy content, and engage in commerce.

Share on Social Networks: